Amundi
AGIO icon

Amundi’s Agios Pharmaceuticals AGIO Stock Holding History

Amundi’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,264
Closed -$95K – 1896
2022
Q3 		$95K Hold
3,264
– – ﹤0.01% 1564
2022
Q2 		$74K Hold
3,264
– – ﹤0.01% 1496
2022
Q1 		$97K Hold
3,264
– – ﹤0.01% 1476
2021
Q4 		$104K Hold
3,264
– – ﹤0.01% 1564
2021
Q3 		$151K Hold
3,264
– – ﹤0.01% 1473
2021
Q2 		$180K Buy
+3,264
New +$183K ﹤0.01% 1398

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Amundi's AGIO Position: Q4 2022 in Review

Amundi sold out of Agios Pharmaceuticals (AGIO) in Q4 2022, closing a stake of 3,264 shares — an estimated $95K sold.

Amundi first reported a position in AGIO in Q2 2021 and held it in 6 quarters. The position peaked at $180K in Q2 2021. 160 funds tracked by Wall St. Rank hold AGIO as of Q4 2022.

  • Amundi reported no remaining Agios Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Amundi sold 3,264 Agios Pharmaceuticals shares in Q4 2022, an estimated $95K.
  • Amundi first reported a position in Agios Pharmaceuticals in Q2 2021 and held it in 6 quarters.
  • Amundi's Agios Pharmaceuticals position peaked at $180K in Q2 2021.
  • 160 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2022.

Based on Amundi's 13F filing for Q4 2022, filed 14 Feb 2023.